Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?.
10.5625/lar.2011.27.4.265
- Author:
Min Ah PARK
1
;
Kyung A HWANG
;
Kyung Chul CHOI
Author Information
1. Laboratory of Veterinary Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea. kchoi@cbu.ac.kr
- Publication Type:Review
- Keywords:
Endocrine disrupting chemicals;
estrogen;
cancer progression;
estrogen receptor
- MeSH:
Adult;
Animals;
Benzhydryl Compounds;
Breast;
Diet;
Dioxins;
Endocrine Disruptors;
Endocrine System;
Estrogens;
Female;
Genistein;
Humans;
Mice;
Models, Animal;
Ovary;
Phenols;
Phytoestrogens;
Prostatic Neoplasms;
Receptors, Estrogen;
Stilbenes
- From:Laboratory Animal Research
2011;27(4):265-273
- CountryRepublic of Korea
- Language:English
-
Abstract:
Acting as hormone mimics or antagonists in the interaction with hormone receptors, endocrine disrupting chemicals (EDCs) have the potentials of disturbing the endocrine system in sex steroid hormone-controlled organs and tissues. These effects may lead to the disruption of major regulatory mechanisms, the onset of developmental disorders, and carcinogenesis. Especially, among diverse EDCs, xenoestrogens such as bisphenol A, dioxins, and di(2-ethylhexyl)phthalate, have been shown to activate estrogen receptors (ERs) and to modulate cellular functions induced by ERs. Furthermore, they appear to be closely related with carcinogenicity in estrogen-dependant cancers, including breast, ovary, and prostate cancers. In in vivo animal models, prenatal exposure to xenoestrogens changed the development of the mouse reproductive organs and increased the susceptibility to further carcinogenic exposure and tumor occurence in adults. Unlike EDCs, which are chemically synthesized, several phytoestrogens such as genistein and resveratrol showed chemopreventive effects on specific cancers by contending with ER binding and regulating normal ER action in target tissues of mice. These results support the notion that a diet containing high levels of phytoestrogens can have protective effects on estrogen-related diseases. In spite of the diverse evidences of EDCs and phytoestrogens on causation and prevention of estrogen-dependant cancers provided in this article, there are still disputable questions about the dose-response effect of EDCs or chemopreventive potentials of phytoestrogens. As a wide range of EDCs including phytoestrogens have been remarkably increasing in the environment with the rapid growth in our industrial society and more closely affecting human and wildlife, the potential risks of EDCs in endocrine disruption and carcinogenesis are important issues and needed to be verified in detail.
